Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.62 -0.88%   SPY: 165.93 -0.74%
Quote Spy UGNE NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Unigene Laboratories (UGNE)

@ May-22
Click the portfolio to add UGNE:
Close [X]
+ Add UGNE to Portfolio
  
  Last Trade: $0.03 +0.01 (24.07%)
  Volume: 61,300 42% of avg daily volume
       
  Avg Volume: 145,289
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.02 - 0.03
  Open: 0.03
  Previous Close: 0.02
  52-wk Range: 0.02 - 0.37
  Market Cap: 2.3M
  P/E: -0.1
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy UGNE

? Pro holders
? Member holders
? Items submitted
Additional UGNE resources



Customize Links
To see which Pros and tickerspy members own UGNE Sign up now
Latest UGNE Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Unigene to Advance Phase 2 Development of Oral PTH Program by Entering into an Amended and Restated Exclusive Worldwide License Agreement with GSK
UGNE  
Linked by BusinessWire - December 13, 08:00AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE) today announced that the Company entered into an amended and restated exclusive  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Completes Executive Management Team and Names Jenene D. Thomas, VP of Investor Relations and Corporate Communications
UGNE  
Linked by BusinessWire - November 23, 07:30AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Announces Financial Results for Third Quarter 2010 and Highlights the Momentum of Its New Corporate Strategy
UGNE  
Linked by BusinessWire - November 09, 05:50PM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE) today announced financial results for the third quarter, 2010 and highlighted progress  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
UGNE  
Linked by BusinessWire - November 02, 07:30AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Bolsters Leadership Team with Two Key Appointments
UGNE  
Linked by BusinessWire - October 04, 07:30AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Expands Board of Directors; Elects Joel A. Tune as Director
UGNE  
Linked by BusinessWire - September 28, 07:30AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Announces Significant Cost Savings and Corporate Restructuring
UGNE  
Linked by BusinessWire - December 09, 07:31AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB:UGNE) (http://www.unigene.com) has announced a restructuring plan that includes a reduction  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics
UGNE  
Linked by BusinessWire - October 20, 07:30AM from (www.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Unigene Announces Financial Results for the Third Quarter of 2007
UGNE  
Linked by BusinessWire - November 12, 06:00AM from (home.businesswire.com)
Unigene Laboratories, Inc. (OTCBB: UGNE) reports its financial results for the three months and nine months ended September  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource